Forming Strategies to Increase Competitiveness in Local Pharmaceutical Enterprises
DOI:
https://doi.org/10.31150/ajebm.v8i7.3830Keywords:
Pharmaceutical Industry, Competitiveness, Local Manufacturer, Innovative Development, Quality Standards, Export Potential, Pharmaceutical Clusters, Technological Modernization, Marketing Strategy, State Support, Supply Chain, Import Dependence, Human Resources PotentialAbstract
This article comprehensively analyzes the issue of increasing the competitiveness of domestic pharmaceutical enterprises in Uzbekistan. Based on the analysis of the reforms being implemented by the state, the current situation in the market, technological and economic opportunities, the problems and development prospects of the industry have been identified. The analysis was conducted based on indicators such as pharmaceutical exports for 2020–2024, sales volumes in the domestic market, import dependence, and compliance with quality standards. Taking into account the theoretical views of scientists, international experience, and local conditions, specific and practical recommendations have been developed to increase the competitiveness of domestic pharmaceutical enterprises.
Downloads
References
[1] M. Porter, Competitive Advantage: Creating and Sustaining Superior Performance. New York: Free Press, 1985.
[2] M. Porter, “Clusters and the New Economics of Competition,” Harvard Business Review, vol. 78, no. 6, pp. 77–90, 2000.
[3] H. Kurbanov, “In Uzbekistan pharmaceuticals field development promising directions,” Economic Analysis Magazine, no. 4, 2020.
[4] J. Yunusov, “Pharmaceuticals in the field market relations and competition environment improvement directions,” Economy and Management Magazine, no. 3, 2019.
[5] Sh. Turaev, “Innovative management based on pharmaceuticals of enterprises competitiveness increase,” UzR Economy and Innovations Magazine, no. 2, 2021.
[6] World Health Organization, Global Pharmaceutical Market Report, WHO, 2022.
[7] International Federation of Pharmaceutical Manufacturers (IFPMA), Building Resilient Pharmaceutical Supply Chains, IFPMA, 2021.
[8] A. Marshall, Principles of Economics, Classic Works Edition, 2018.
[9] Republic of Uzbekistan, Presidential Decree No. PQ-4707, “On the State Program 'Pharma-2023',” May 6, 2020.
[10] ISO & GMP Pharmaceuticals Standards Set, Tashkent, 2021.
[11] P. Kotler and K. Keller, Marketing Management, 15th ed., Pearson Education, 2016.
[12] G. S. Becker, Human Capital: A Theoretical and Empirical Analysis, University of Chicago Press, 1993.
[13] S. Latifovich, “Branding Strategies for Improving Competitiveness in Local Pharmaceutical Companies,” in Proc. GlobalBiz Summit: Business and Economic Strategies for the Future, vol. 1, pp. 1–5, 2025.
[14] L. B. Likuyani, “Strategies adopted by multinational pharmaceutical corporations to cope with competition in Kenya,” 2015.
[15] R. O. Salimbaeva, A. A. Tagay, A. Bulambaev, and K. Meyrambek, “Formation and Implementation of Competitive Strategies in Pharmaceutical Companies,” Of Biological and Medical, vol. 17, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Khasanov Sokhib Latifovich
This work is licensed under a Creative Commons Attribution 4.0 International License.
